Evidence map›Paper›PMID 41940102›Full record

ArticleFrontiers in artificial intelligence2026

Transformers meet CNNs for insights into breast mass classification from histopathological images.

Vatsala Anand, Ajay Khajuria

Abstract read
In one paragraph

Article in Frontiers in artificial intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Vatsala AnandDepartment of Computer Science and Engineering, Akal University, Bathinda, Punjab, India.
Ajay KhajuriaDepartment of Chemistry, Akal University, Bathinda, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Breast cancer remains one of the leading causes of cancer-related deaths among women worldwide, highlighting the critical need for accurate histopathological diagnosis and reliable decision-support systems to improve diagnostic sensitivity and reduce false-negative outcomes. Methods: In this research, a deep learning-based approach for binary classification of breast cancer into benign and malignant categories utilizing histopathological images is presented. A dataset comprising 10,000 high-resolution histopathology images was used to evaluate the execution of two vision models: Swin Transformer V2 and ConvNeXt V2. Swin Transformer V2, a progressive vision transformer with shifted window self-attention, and ConvNeXt V2, a modern convolutional neural network motivated by transformer plans, were fine-tuned and tested for their adequacy in feature representation and classification accuracy. Results: The experimental results demonstrate that Swin Transformer V2 consistently outperforms ConvNeXt V2 across all evaluation metrics, achieving a peak classification accuracy of 0.985, which reflects its superior capability in capturing subtle morphological and contextual variations in histopathological tissues. Discussion: The attention-driven global feature modeling in Swin Transformer V2 enables more discriminative representations compared to convolutional inductive biases, particularly for complex cellular patterns. These findings suggest that transformer-based architectures offer significant advantages over modern CNNs for histopathological breast cancer classification, and they hold substantial potential for advancing computer-aided diagnosis systems in digital pathology. The comparative insights provided in this study can guide the selection of robust deep learning models for scalable and reliable clinical decision-support systems.

Indexed as

breast tumorsclassificationConvNeXt V2histopathologymammographymedical image analysisSwin Transformer V2vision transformers

Identifiers

PMID41940102
PMCPMC13044970

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.